基于病毒载体和病毒样颗粒的疫苗对抗传染病:一篇小评
Ruth Henríquez1, Isabel Muñoz-Barroso1
1Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Edificio Departamental Lab.106. Plaza Doctores de la Reina S/n, 37007, Salamanca, Spain.
Heliyon
|August 15, 2024
概括
新的疫苗平台,如病毒载体和类似病毒的粒子 (VLPs) 提供对传染病的快速保护. 这些先进的疫苗学工具对于有效应对新出现的流行病威胁至关重要.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 传染病研究 传染病研究
- 生物技术是生物技术.
背景情况:
- 传统疫苗在有效性和发展速度方面存在局限性.
- 病毒载体和病毒样粒子 (VLP) 平台代表了创新的疫苗设计策略.
- 这些平台利用病毒组件提高免疫性和快速反应能力.
研究的目的:
- 审查病毒载体和VLP疫苗平台的进展和应用.
- 突出这些新方法在打击传染病和流行病方面的意义.
- 为了强调它们在现代疫苗学中的作用.
主要方法:
- 关于病毒载体和VLP疫苗开发的科学文献的综述.
- 分析使用这些平台的授权疫苗和临床候选疫苗.
- 检查作用机制和与传统疫苗相比的优势.
主要成果:
- 病毒载体疫苗表现出高效率和快速开始的保护.
- 已批准的病毒载体疫苗针对包括日本脑炎,拉萨热,埃博拉,乙肝和乙肝,SARS-CoV-2和疟疾在内的疾病.
- 商业化VLP疫苗可用于B型肝炎和E型肝炎,人类乳头瘤病毒和疟疾.
- 针对COVID-19的加速疫苗生产例证了这些平台的潜力.
结论:
- 病毒载体和VLP平台是现代疫苗学的重要工具.
- 这些创新方法能够迅速应对新出现的病原体和流行病威胁.
- 这些平台的成功有望增强全球卫生安全.
相关概念视频
00:56Viral Structure
62.0K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
62.0K
00:57Viral Recombination
23.3K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.3K
01:51Vaccinations
44.2K
Overview
44.2K